Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

"They Don't Think Like Us": Exploring Attitudes of Non-Transgender Students Toward Transgender People Using Discourse Analysis.

Robson Day C, Nicholls K.

J Homosex. 2019 Oct 25:1-20. doi: 10.1080/00918369.2019.1667161. [Epub ahead of print]

PMID:
31652111
2.

Optimised approach to albumin-drug conjugates using monobromomaleimide-C-2 linkers.

Wall A, Nicholls K, Caspersen MB, Skrivergaard S, Howard KA, Karu K, Chudasama V, Baker JR.

Org Biomol Chem. 2019 Aug 28;17(34):7870-7873. doi: 10.1039/c9ob00721k.

PMID:
31410415
3.

Management of refractory lupus nephritis: challenges and solutions.

Yo JH, Barbour TD, Nicholls K.

Open Access Rheumatol. 2019 Jul 12;11:179-188. doi: 10.2147/OARRR.S166303. eCollection 2019. Review.

4.

Summer surface melt thins Petermann Gletscher Ice Shelf by enhancing channelized basal melt.

Washam P, Nicholls KW, Mühow A, Padman L.

J Glaciol. 2019;N/A:1-13. doi: 10.1017/jog.2019.43. Epub 2019 Jul 9.

PMID:
31359886
5.

Rapid mixing and exchange of deep-ocean waters in an abyssal boundary current.

Naveira Garabato AC, Frajka-Williams EE, Spingys CP, Legg S, Polzin KL, Forryan A, Abrahamsen EP, Buckingham CE, Griffies SM, McPhail SD, Nicholls KW, Thomas LN, Meredith MP.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13233-13238. doi: 10.1073/pnas.1904087116. Epub 2019 Jun 18.

6.

Physical Conditions of Fast Glacier Flow: 3. Seasonally-Evolving Ice Deformation on Store Glacier, West Greenland.

Young TJ, Christoffersen P, Doyle SH, Nicholls KW, Stewart CL, Hubbard B, Hubbard A, Lok LB, Brennan PV, Benn DI, Luckman A, Bougamont M.

J Geophys Res Earth Surf. 2019 Jan;124(1):245-267. doi: 10.1029/2018JF004821. Epub 2019 Jan 30.

7.

Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2.

Slade CA, McLean C, Scerri T, Giang TB, Megaloudis S, Strathmore A, Tempany JC, Nicholls K, D'Arcy C, Bahlo M, Hodgkin PD, Douglass JA, Bryant VL.

J Clin Immunol. 2019 Apr;39(3):324-335. doi: 10.1007/s10875-019-00602-x. Epub 2019 Mar 29.

PMID:
30927119
8.

Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study.

Hughes DA, Nicholls K, Sunder-Plassmann G, Jovanovic A, Feldt-Rasmussen U, Schiffmann R, Giugliani R, Jain V, Viereck C, Castelli JP, Skuban N, Barth JA, Bichet DG.

Am J Med Genet A. 2019 Jun;179(6):1069-1073. doi: 10.1002/ajmg.a.61105. Epub 2019 Mar 28. No abstract available.

9.

Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial.

Schiffmann R, Goker-Alpan O, Holida M, Giraldo P, Barisoni L, Colvin RB, Jennette CJ, Maegawa G, Boyadjiev SA, Gonzalez D, Nicholls K, Tuffaha A, Atta MG, Rup B, Charney MR, Paz A, Szlaifer M, Alon S, Brill-Almon E, Chertkoff R, Hughes D.

J Inherit Metab Dis. 2019 May;42(3):534-544. doi: 10.1002/jimd.12080. Epub 2019 Apr 8.

PMID:
30834538
10.

Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.

Germain DP, Nicholls K, Giugliani R, Bichet DG, Hughes DA, Barisoni LM, Colvin RB, Jennette JC, Skuban N, Castelli JP, Benjamin E, Barth JA, Viereck C.

Genet Med. 2019 Sep;21(9):1987-1997. doi: 10.1038/s41436-019-0451-z. Epub 2019 Feb 6.

11.

A new class of recombinant human albumin with multiple surface thiols exhibits stable conjugation and enhanced FcRn binding and blood circulation.

Schelde KK, Nicholls K, Dagnæs-Hansen F, Bunting K, Rawsthorne H, Andersen B, Finnis CJA, Williamson M, Cameron J, Howard KA.

J Biol Chem. 2019 Mar 8;294(10):3735-3743. doi: 10.1074/jbc.RA118.005870. Epub 2019 Jan 2.

PMID:
30602565
12.

Elevated Lyso-Gb3 Suggests the R118C GLA Mutation Is a Pathological Fabry Variant.

Talbot A, Nicholls K.

JIMD Rep. 2019;45:95-98. doi: 10.1007/8904_2018_146. Epub 2018 Dec 20.

13.

Giri-nya-la-nha (talk together) to explore acceptability of targeted smoking cessation resources with Australian Aboriginal women.

Bovill M, Bar-Zeev Y, Gruppetta M, Clarke M, Nicholls K, O'Mara P, Bonevski B, Reath J, Gould G.

Public Health. 2018 Nov 1. pii: S0033-3506(18)30277-4. doi: 10.1016/j.puhe.2018.08.010. [Epub ahead of print]

14.

Absence of renal phenotype in hereditary haemorrhagic telangiectasia.

Healy L, Nicholls K, Gibson R, Stella D, Bogwitz M, Taylor J, Walsh M, Donaldson L, Winship I.

Intern Med J. 2018 Oct;48(10):1255-1257. doi: 10.1111/imj.14059.

PMID:
30288899
15.

A seven-year retrospective review of colonoscopy records from a single centre in Zambia.

Kayamba V, Nicholls K, Morgan C, Kelly P.

Malawi Med J. 2018 Mar;30(1):17-21. doi: 10.4314/mmj.v30i1.4.

16.

Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian Adults.

Slade CA, Bosco JJ, Binh Giang T, Kruse E, Stirling RG, Cameron PU, Hore-Lacy F, Sutherland MF, Barnes SL, Holdsworth S, Ojaimi S, Unglik GA, De Luca J, Patel M, McComish J, Spriggs K, Tran Y, Auyeung P, Nicholls K, O'Hehir RE, Hodgkin PD, Douglass JA, Bryant VL, van Zelm MC.

Front Immunol. 2018 May 14;9:694. doi: 10.3389/fimmu.2018.00694. eCollection 2018.

17.

Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial.

Schiffmann R, Bichet DG, Jovanovic A, Hughes DA, Giugliani R, Feldt-Rasmussen U, Shankar SP, Barisoni L, Colvin RB, Jennette JC, Holdbrook F, Mulberg A, Castelli JP, Skuban N, Barth JA, Nicholls K.

Orphanet J Rare Dis. 2018 Apr 27;13(1):68. doi: 10.1186/s13023-018-0813-7.

18.

Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study.

Germain DP, Brand E, Burlina A, Cecchi F, Garman SC, Kempf J, Laney DA, Linhart A, Maródi L, Nicholls K, Ortiz A, Pieruzzi F, Shankar SP, Waldek S, Wanner C, Jovanovic A.

Mol Genet Genomic Med. 2018 Apr 12. doi: 10.1002/mgg3.389. [Epub ahead of print]

19.

Chemoselective Installation of Amine Bonds on Proteins through Aza-Michael Ligation.

Freedy AM, Matos MJ, Boutureira O, Corzana F, Guerreiro A, Akkapeddi P, Somovilla VJ, Rodrigues T, Nicholls K, Xie B, Jiménez-Osés G, Brindle KM, Neves AA, Bernardes GJL.

J Am Chem Soc. 2017 Dec 20;139(50):18365-18375. doi: 10.1021/jacs.7b10702. Epub 2017 Dec 5.

20.

Training Community Health Workers to Enhance Disaster Resilience.

Nicholls K, Picou SJ, McCord SC.

J Public Health Manag Pract. 2017 Nov/Dec;23 Suppl 6 Suppl, Gulf Region Health Outreach Program:S78-S84. doi: 10.1097/PHH.0000000000000645.

PMID:
28961657
21.

Australian and New Zealand Anaesthetic Allergy Group Perioperative Anaphylaxis Investigation Guidelines.

Scolaro RJ, Crilly HM, Maycock EJ, McAleer PT, Nicholls KA, Rose MA, The R.

Anaesth Intensive Care. 2017 Sep;45(5):543-555.

22.

A simple method for quantification of plasma globotriaosylsphingosine: Utility for Fabry disease.

Talbot A, Nicholls K, Fletcher JM, Fuller M.

Mol Genet Metab. 2017 Sep;122(1-2):121-125. doi: 10.1016/j.ymgme.2017.08.004. Epub 2017 Aug 19.

PMID:
28847675
23.

Mastocytosis: a case series of 107 consecutive patients.

Bhullar H, Martyres R, Nicholls K, Varigos G, Douglass J, Saracino A.

Br J Dermatol. 2018 Jan;178(1):e28-e29. doi: 10.1111/bjd.15729. Epub 2017 Dec 6. No abstract available.

PMID:
28621448
24.

Albumin-based drug delivery using cysteine 34 chemical conjugates - important considerations and requirements.

Caspersen MB, Kuhlmann M, Nicholls K, Saxton MJ, Andersen B, Bunting K, Cameron J, Howard KA.

Ther Deliv. 2017 Jul;8(7):511-519. doi: 10.4155/tde-2017-0038. Epub 2017 May 30.

PMID:
28555530
25.

Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry.

Wilcox WR, Feldt-Rasmussen U, Martins AM, Ortiz A, Lemay RM, Jovanovic A, Germain DP, Varas C, Nicholls K, Weidemann F, Hopkin RJ.

JIMD Rep. 2018;38:45-51. doi: 10.1007/8904_2017_28. Epub 2017 May 17.

26.

Engineered Polymer-Transferrin Conjugates as Self-Assembling Targeted Drug Delivery Systems.

Makwana H, Mastrotto F, Magnusson JP, Sleep D, Hay J, Nicholls KJ, Allen S, Alexander C.

Biomacromolecules. 2017 May 8;18(5):1532-1543. doi: 10.1021/acs.biomac.7b00101. Epub 2017 Apr 11.

PMID:
28350442
27.

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.

Hughes DA, Nicholls K, Shankar SP, Sunder-Plassmann G, Koeller D, Nedd K, Vockley G, Hamazaki T, Lachmann R, Ohashi T, Olivotto I, Sakai N, Deegan P, Dimmock D, Eyskens F, Germain DP, Goker-Alpan O, Hachulla E, Jovanovic A, Lourenco CM, Narita I, Thomas M, Wilcox WR, Bichet DG, Schiffmann R, Ludington E, Viereck C, Kirk J, Yu J, Johnson F, Boudes P, Benjamin ER, Lockhart DJ, Barlow C, Skuban N, Castelli JP, Barth J, Feldt-Rasmussen U.

J Med Genet. 2017 Apr;54(4):288-296. doi: 10.1136/jmedgenet-2016-104178. Epub 2016 Nov 10. Erratum in: J Med Genet. 2018 Apr 16;:.

28.

ITER-like antenna capacitors voltage probes: Circuit/electromagnetic calculations and calibrations.

Helou W, Dumortier P, Durodié F, Lombard G, Nicholls K; JET Contributors.

Rev Sci Instrum. 2016 Oct;87(10):104705.

PMID:
27802745
29.

Retinal disease in the C3 glomerulopathies and the risk of impaired vision.

Savige J, Amos L, Ierino F, Mack HG, Symons RC, Hughes P, Nicholls K, Colville D.

Ophthalmic Genet. 2016 Dec;37(4):369-376. Epub 2016 Feb 25. Review.

PMID:
26915021
30.

Local and intercontinental comparisons of test morphology in the little-known testate amoeba Cyphoderia laevis Penard.

Nicholls KH, Török JK.

Eur J Protistol. 2016 Oct;56:67-78. doi: 10.1016/j.ejop.2016.07.001. Epub 2016 Jul 19.

PMID:
27541188
31.

Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.

Germain DP, Hughes DA, Nicholls K, Bichet DG, Giugliani R, Wilcox WR, Feliciani C, Shankar SP, Ezgu F, Amartino H, Bratkovic D, Feldt-Rasmussen U, Nedd K, Sharaf El Din U, Lourenco CM, Banikazemi M, Charrow J, Dasouki M, Finegold D, Giraldo P, Goker-Alpan O, Longo N, Scott CR, Torra R, Tuffaha A, Jovanovic A, Waldek S, Packman S, Ludington E, Viereck C, Kirk J, Yu J, Benjamin ER, Johnson F, Lockhart DJ, Skuban N, Castelli J, Barth J, Barlow C, Schiffmann R.

N Engl J Med. 2016 Aug 11;375(6):545-55. doi: 10.1056/NEJMoa1510198.

32.

Assessing for Unilateral Spatial Neglect Using Eye-Tracking Glasses: A Feasibility Study.

Kortman B, Nicholls K.

Occup Ther Health Care. 2016 Aug 5:1-12. [Epub ahead of print]

PMID:
27494287
33.

Bull's eye and pigment maculopathy are further retinal manifestations of an abnormal Bruch's membrane in Alport syndrome.

Savige J, Wang Y, Crawford A, Smith J, Symons A, Mack H, Nicholls K, Wilson D, Colville D.

Ophthalmic Genet. 2017 May-Jun;38(3):238-244. doi: 10.1080/13816810.2016.1210648. Epub 2016 Aug 2.

PMID:
27485810
34.

Observed vulnerability of Filchner-Ronne Ice Shelf to wind-driven inflow of warm deep water.

Darelius E, Fer I, Nicholls KW.

Nat Commun. 2016 Aug 2;7:12300. doi: 10.1038/ncomms12300.

35.

Pregnancy complicated by haemorrhagic ascites in a woman with newly diagnosed HIV.

Morgan C, Nicholls K, Gangat N, Sansome S.

BMJ Case Rep. 2016 Jul 29;2016. pii: bcr2016216346. doi: 10.1136/bcr-2016-216346.

36.

Immunoglobulin E-Mediated Hypersensitivity Reaction to Ketamine.

Ozcan J, Nicholls K, Jones K.

Pain Pract. 2016 Sep;16(7):E94-8. doi: 10.1111/papr.12466. Epub 2016 Jun 23.

PMID:
27334139
37.

Single-dose rituximab in refractory lupus nephritis.

Kotagiri P, Martin A, Hughes P, Becker G, Nicholls K.

Intern Med J. 2016 Aug;46(8):899-901. doi: 10.1111/imj.13136.

PMID:
27242250
38.

Fabry in the older patient: Clinical consequences and possibilities for treatment.

Lidove O, Barbey F, Niu DM, Brand E, Nicholls K, Bizjajeva S, Hughes DA.

Mol Genet Metab. 2016 Aug;118(4):319-25. doi: 10.1016/j.ymgme.2016.05.009. Epub 2016 May 14.

39.

Bimodal Winter Haul-Out Patterns of Adult Weddell Seals (Leptonychotes weddellii) in the Southern Weddell Sea.

Boehme L, Baker A, Fedak M, Årthun M, Nicholls K, Robinson P, Costa D, Biuw M, Photopoulou T.

PLoS One. 2016 May 19;11(5):e0155817. doi: 10.1371/journal.pone.0155817. eCollection 2016.

40.

Sleep Disturbance, Obstructive Sleep Apnoea and Abnormal Periodic Leg Movements: Very Common Problems in Fabry Disease.

Talbot A, Hammerschlag G, Goldin J, Nicholls K.

JIMD Rep. 2017;31:37-44. doi: 10.1007/8904_2016_549. Epub 2016 Mar 24.

41.

Anorexia nervosa: a mistaken diagnosis.

Nicholls K, Boggis N, Pandya N.

BMJ Case Rep. 2016 Mar 22;2016. pii: bcr2015214058. doi: 10.1136/bcr-2015-214058.

42.
43.

Differences in Colorectal Cancer Risk Knowledge Among Alabamians: Screening Implications.

Oliver JS, Ewell P, Nicholls K, Chapman K, Ford S.

Oncol Nurs Forum. 2016 Jan;43(1):77-85. doi: 10.1188/16.ONF.77-85.

PMID:
26679447
44.

Finding the fifth intercostal space for chest drain insertion: guidelines and ultrasound.

Bowness JS, Nicholls K, Kilgour PM, Ferris J, Whiten S, Parkin I, Mooney J, Driscoll P.

Emerg Med J. 2015 Dec;32(12):951-4. doi: 10.1136/emermed-2015-205222. Epub 2015 Oct 5.

PMID:
26438727
45.

Providing effective evidence for the coroner.

George B, Nicholls K, Pompeus S, Vasu V.

Arch Dis Child Educ Pract Ed. 2016 Apr;101(2):82-6. doi: 10.1136/archdischild-2015-308584. Epub 2015 Sep 24. Review. No abstract available.

PMID:
26405225
46.

Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase.

Warnock DG, Bichet DG, Holida M, Goker-Alpan O, Nicholls K, Thomas M, Eyskens F, Shankar S, Adera M, Sitaraman S, Khanna R, Flanagan JJ, Wustman BA, Barth J, Barlow C, Valenzano KJ, Lockhart DJ, Boudes P, Johnson FK.

PLoS One. 2015 Aug 7;10(8):e0134341. doi: 10.1371/journal.pone.0134341. eCollection 2015.

47.

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease.

Goláň L, Goker-Alpan O, Holida M, Kantola I, Klopotowski M, Kuusisto J, Linhart A, Musial J, Nicholls K, Gonzalez-Rodriguez D, Sharma R, Vujkovac B, Chang P, Wijatyk A.

Drug Des Devel Ther. 2015 Jul 8;9:3435-44. doi: 10.2147/DDDT.S80928. eCollection 2015.

48.

Lipiduria--with special relevance to Fabry disease.

Becker GJ, Nicholls K.

Clin Chem Lab Med. 2015 Nov;53 Suppl 2:s1465-70. doi: 10.1515/cclm-2015-0499. Review.

49.

An unusual urticarial eruption: Familial cold autoinflammatory syndrome.

Nguyen R, Robinson A, Nicholls K, Varigos G, Dolianitis C.

Australas J Dermatol. 2015 Jun 26:e133-e136. doi: 10.1111/ajd.12361. Epub 2015 Jun 26. Retraction in: Nguyen R, Robinson A, Nicholls K, Varigos G, Dolianatis C. Aust Dent J. 2015 Sep;60(3):e1.

PMID:
26115477
50.

A platform for efficient, thiol-stable conjugation to albumin's native single accessible cysteine.

Smith ME, Caspersen MB, Robinson E, Morais M, Maruani A, Nunes JP, Nicholls K, Saxton MJ, Caddick S, Baker JR, Chudasama V.

Org Biomol Chem. 2015 Aug 7;13(29):7946-9. doi: 10.1039/c5ob01205h. Epub 2015 Jun 25.

Supplemental Content

Loading ...
Support Center